New Key Statistics Module, Z-Score and F-Score
NAS:LPTX Key Ratios
Market Cap $ M | 85.71 |
Enterprise Value $ M | 29.08 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.21 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -2.13 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 13.20 |
5-y EBITDA Growth Rate % | 25.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.54 |
EV-to-EBITDA | -0.54 |
PEG | -- |
Shares Outstanding M | 38.26 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 5.38 |
Current Ratio | 5.38 |
ROA % (ttm) | -64.11 |
ROE % (ttm) | -91.42 |
ROIC % (ttm) | -2,892.26 |
Dividend Yield % | -- |
Altman Z-Score | -- |
LPTX Number of Guru Trades
LPTX Volume of Guru Trades
Gurus Latest Trades with NAS:LPTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LPTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Leap Therapeutics Inc Insider Transactions
No Available Data
News about NAS:LPTX
Total 0- 1